Dr Kiran Piparva

Pharmacology 

Dr. Kiran G. Piparva

Assistant Professor

M.D. Pharmacology

    Email: kiranpiparva@yahoo.co.in

    1. Research work / publications

     

    1. Piparva KG, Parmar DM, Singh AP, Gajera MV, Trivedi HR. Drug utilization study of      psychotropic drugs in outdoor patients in a teaching hospital. Indian J Psychol Med 2011;33: 54-8.

     

    1. Piparva KG, Buch JG, Chandrani KV. Analysis of adverse drug reactions of atypical antipsychotic drugs in psychiatry OPD. Indian J Psychol Med 2011;33: 153-7.

     

    1. Dela AI, Tank ND, Singh AP, Piparva KG. Adverse drug reactions and treatment outcome analysis of DOTS plus therapy of MDR-TB patients at district tuberculosis centre: A four-year retrospective study. Lung India 2017;34: 522-6.

     

    1. Thakkar D, Piparva KG, Lakkad SG. A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district. Lung India 2019; 36:108-11. (INDEXED)

     

    1. Karelia BN, Piparva KG. Knowledge, attitude and practice of pharmacovigilance among private healthcare professionals of Rajkot city. Int J Basic Clin Pharmacol 2014; 3:50-3. (INDEXED)

     

    1. Piparva KG, Buch JG. Deep vein thrombosis in a woman taking oral combined contraceptive pills. Journal of Pharmacology & Pharmacotherapeutics. 2011 Jul;2(3):185-186. DOI: 10.4103/0976-500x.83284.

     

    1. Agravat VJ, Agarwal S, Piparva KG. Crimean - Congo haemorrhagic fever: an overview. Int J Res Med Sci 2014; 2:392-7.

     

    1. Piparva KG, Jansari G, Singh AP. Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients at district tuberculosis centre Rajkot. Perspect Clin Res. 2018 Oct-Dec; 9(4): 165–169.doi: 10.4103/picr.PICR_165_17.

     

    1. Piparva KG: Treatment outcome of tuberculosis patients on dots therapy for category 1 and 2 at district tuberculosis centre. Int J Pharm Sci Res 2017; 8(1): 207-12.doi: 10.13040/IJPSR.0975-8232.8(1).207-12.

     

    1. Piparva KG, Singh AP. A Cross Sectional Pilot Study of Knowledge, Attitude and Practice of Pharmacovigilance among Pharmacists at Rajkot District. J Basic Clin Pharma 2017;8: S20-S23.

     

    1. Parul AP, Bharti NK and Kiran GP: Dysmenorrhoea: prevalence, impact and knowledge aspect of treatment in females of reproductive age in tertiary care teaching hospital. Int J Pharm Sci Res 2016; 7(11): 4556-60.doi: 10.13040/IJPSR.0975-8232.7(11).4556-60.

     

    1. Savaliya SM, Singh AP, Piparva KG. A donor hemovigilance study: evaluation of adverse reactions to blood donors at tertiary care teaching hospital. Int J Basic Clin Pharmacol 2019; 8:1538-41.

     

    1. Lalwani US, Pillai A and Piparva KG: Drug utilization pattern among geriatric patients in a tertiary care teaching hospital. Int J Pharm Sci Res 2017; 8(3): 1249-54.doi: 10.13040/IJPSR.0975-8232.8(3).1249-54.

     

    1. Patel BS, Kubavat A, Piparva K. Correlation of student's performance in theory and practical of final summative pharmacology examination in M.B.B.S curriculum: A critical insight. Natl J Physiol Pharm Pharmacol 2013; 3:171-175.1.

     

    1. Damor RR, Kubavat AR, Piparva KG. Drug reaction with eosinophilia and systemic symptom induced by carbamazepine: a case report. Int J Basic Clin Pharmacol 2019; 8:1115-8.

     

    1. Karelia BN, Piparva KG, Patel P. Prescription pattern study in type 2 diabetes mellitus in diabetic out patients at private clinic. European Journal of Molecular & Clinical Medicine, 2021, 8 (4) P: 79-87

     

    1. Kiran PG, Anil SP, Karmur M. Prescription pattern and cost variation analysis in type 2 diabetes mellitus patients at private outpatient department. 2021;12: 11-14.

     

    1. Piparva KG, Singh AP, Joshi N. Compliance of appointment, antidiabetic treatment and diet among type 2 diabetes mallitus at private diabetes clinic. Dubai Diabetes Endocrinol J. DOI: 10.1159/000525373.

     

     

    1. Area of interest: Research, Academic, Pharmacovigilance

     

    1. Membership of professional/academic/research bodies:

     

          1. Indian Journal of pharmacology (IJP)
          2. Indian Medical Association (IMA)
          3. National Medical Organization (NMO)
          4. Association of Physiologist and Pharmacologist of India (APPI)